TARIS Biomedical Garners $18,300,000 Series B Round

  • Feed Type
  • Date
    4/13/2011
  • Company Name
    TARIS Biomedical
  • Mailing Address
    99 Hayden Avenue Lexington, MA 02421
  • Company Description
    TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
  • Website
    http://www.tarisbiomedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,300,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This investment will allow us to advance our lead product candidate, Lidocaine Releasing Intravesical System (LiRIS®), into later stage clinical development for the treatment of multiple bladder disorders, and to continue to build the rest of our pipeline of novel therapeutics, leveraging common, minimally invasive urological procedures. The company’s prior bridge financing was also converted into equity in connection with the round.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Polaris Venture Partners

By posting a comment, you agree to our terms and conditions.